newsfilter
← Latest News
Business Wire·

Travere Therapeutics Announces Planned Retirement of Chief Research Officer in 2027

William Rote, Ph.D., chief research officer plans to retire in early 2027 Jula Inrig, M.D., to be named executive vice president, head of research and development and CMO, expanding her responsibilities to include the